USPTO 2015–2025 USPTO PatentsView US Corporation

SanBio, Inc.

USPTO PatentsView assignee record - 30 granted patents across 9 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

RSS updates for this company

The verdict

According to USPTO PatentsView, Sanbio ranks #10,445 of 49,997 tracked US assignees by granted-patent volume, with 30 patents across 9 technology areas.

#10,445
of 49,997 US assignees by volume
49th percentile
by Innovation Score (34.9/100)
14.7
avg claims per patent
-19%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10445 · US Corporation #10,445 · 30 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

  • GRANTS-SMALL 30 grants
  • UPPER-Q #10,445/49,997
  • PHOTO-FINISH Sensible Medical…
  • CPC-NARROW C12N · 9 areas
  • INNOV-THIN 34.9/100
  • CLAIMS-RICH 14.7 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DOWN -19% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Sensible Medical Innovations Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Sanbio’s 34.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Sanbio

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Sanbio's Innovation Score is 34.9/100 (49th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Sanbio?

Each dot is one of Sanbio’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Sanbio’s own 14.7 claims/patent is ABOVE the 14.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Sanbio vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 29.93030.1 010203040 Granted patents (volume) Avg claims / patent Sonendo, Inc. - 30, 30.3SonendoSPX Cooling Technologies, Inc. - 30, 13.97SPX CoolingStructured I, LLC - 30, 21.63Structured ISuven Life Sciences Limited - 30, 14.27Suven Life Scienc…Sensible Medical Innovations Ltd. - 30, 22.3Sensible Medical…Sentry Solutions Products Group LLC - 30, 14.27Sentry Solutions…Sequent Medical, Inc. - 30, 19.47Sequent MedicalShenzhen Breo Technology Co., Ltd. - 30, 4.9Shenzhen Breo Tec…SanBio, Inc. - 30, 14.67Sanbio
Sanbio vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Sanbio's grants concentrate

SanBio, Inc. is a focused PatentsView assignee: 9 CPC subclasses with 90% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2019 (7 grants) versus a trough of 1 in 2018. By volume, Sanbio sits between Sonendo, Inc. and Shenzhen Breo Technology Co., Ltd..

Sanbio's three-year grant acceleration

SanBio, Inc. shows 7 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at SanBio's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows SanBio holds 30 patents at rank #10,457, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near SanBio

By rank, the assignees closest to #10,457 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in SanBio's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for SanBio, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), SanBio ranks #400 of 4,144 assignees by patent count in that subclass.

Sanbio's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 49th percentile higher than 49% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 2015201620172018201920202021202220242025 1
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
SanBio, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 2 6.7%
2016 3 10.0%
2017 3 10.0%
2018 1 3.3%
2019 7 23.3%
2020 4 13.3%
2021 2 6.7%
2022 3 10.0%
2024 4 13.3%
2025partial year 1 3.3%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

SanBio, Inc.'s patent record in context - here's where to go next.

  • SanBio, Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 90% of its portfolio - see every assignee active in that class. Explore C12N
  • Ranked #10,445 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare SanBio, Inc. against Sonendo, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 34.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.